POINT-GUARD™
Cerebral embolic protection during Transcatheter Aortic Valve Replacement (TAVR)
Key Facts
About Transverse Medical
Transverse Medical is a private, pre-revenue medical device company founded in 2018, headquartered in San Carlos, California. The company is developing the POINT-GUARD™ device, a cerebral embolic protection system aimed at preventing stroke and silent brain injury during transcatheter aortic valve replacement (TAVR) and other structural heart procedures. Led by co-founder and CEO Eric Goslau, the company is addressing a significant unmet clinical need where periprocedural stroke rates remain a major concern. Its technology is designed to offer comprehensive brain coverage, potentially improving patient outcomes and reducing healthcare costs associated with stroke complications.
View full company profile